Multiple sclerosis in US minority populations: Clinical practice insights

Neurology: Clinical Practice

Volumn 5, Issue 2, 2015, Pages 132-142

  Khan, Omar ^a   Williams, Mitzi J ^b   Amezcua, Lilyana ^c   Javed, Adil ^d   Larsen, Kristin E ^e   Smrtka, Jennifer M ^f  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Multiple Sclerosis Center of Atlanta   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e ProEd Communications Inc   (United States)

^f South Florida Neurology Associates PA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); CULTURAL FACTOR; DISEASE COURSE; DISEASE MANAGEMENT; ETHNIC DIFFERENCE; ETHNIC GROUP; EVIDENCE BASED PRACTICE; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; HEALTH BELIEF; HEALTH CARE DISPARITY; HEALTH ECONOMICS; HEREDITY; HUMAN; INCIDENCE; MANAGED CARE; MEDICATION COMPLIANCE; MULTIPLE SCLEROSIS; PATIENT ATTITUDE; PATIENT EDUCATION; PHASE 4 CLINICAL TRIAL (TOPIC); POPULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIGION; SOCIAL STATUS; SOCIOECONOMICS; TREATMENT OUTCOME; TREATMENT RESPONSE; TRUST; UNITED STATES;

EID: 84927936209     PISSN: 21630402     EISSN: 21630933     Source Type: Journal    
DOI: 10.1212/CPJ.0000000000000112     Document Type: Article

References (20)

1. Munoz-Culla M, Irizar H, Otaegui D. The genetics of multiple sclerosis: review of current and emerging candidates. Appl Clin Genet 2013;6:63-73.
2. Buchanan R, Huang C. Health-related quality of life among informal caregivers assisting people with multiple sclerosis. Disabil Rehabil 2011;33:113-121.
3. Kingwell E, Marriott JJ, Jette N, et al. Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurol 2013;13:128.
4. Amezcua L, Lund BT, Weiner LP, Islam T. Multiple sclerosis in Hispanics: a study of clinical disease expression. Mult Scler 2011;17:1010-1016.
5. Diaz V. Encouraging participation of minorities in research studies. Ann Fam Med 2012;10: 372-373.
6. Durant RW, Legedza AT, Marcantonio ER, Freeman MB, Landon BE. Different types of distrust in clinical research among whites and African Americans. J Natl Med Assoc 2011;103:123-130.
7. Langer-Gould A, Brara SM, Beaber BE, Zhang JL. Incidence of multiple sclerosis in multiple racial and ethnic groups. Neurology 2013;80:1734-1739.
8. Wallin MT, Culpepper WJ, Coffman P, et al. The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service. Brain 2012;135:1778-1785.
9. Cree BA, Reich DE, Khan O, et al. Modification of multiple sclerosis phenotypes by African ancestry at HLA. Arch Neurol 2009;66:226-233.
10. Marrie RA, Cutter G, Tyry T, Vollmer T, Campagnolo D. Does multiple sclerosis-associated disability differ between races? Neurology 2006;66:1235-1240.
11. Kister I, Chamot E, Bacon JH, et al. Rapid disease course in African Americans with multiple sclerosis. Neurology 2010;75:217-223.
12. Buchanan RJ, Zuniga M.A, Carrillo-Zuniga G, et al. Comparisons of Latinos, African Americans, and Caucasians with multiple sclerosis. Ethn Dis 2010;20:451-457.
13. Baranzini SE, Galwey NW, Wang J, et al. Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet 2009;18:2078-2090.
14. Sperandeo K, Nogrady L, Moreo K, Prostko CR. Managed approaches to multiple sclerosis in special populations. J Manag Care Pharm 2011;17:S1-S19; quiz S20-S21.
15. Cree BA, Al-Sabbagh A, Bennett R, Goodin D. Response to interferon beta-1a treatment in African American multiple sclerosis patients. Arch Neurol 2005;62:1681-1683.
16. Klineova S, Nicholas J, Walker A. Response to disease modifying therapies in African Americans with multiple sclerosis. Ethn Dis 2012;22:221-225.
17. Minden SL, Hoaglin DC, Hadden L, Frankel D, Robbins T, Perloff J. Access to and utilization of neurologists by people with multiple sclerosis. Neurology 2008;70:1141-1149.
18. Shabas D, Heffner M. Multiple sclerosis management for low-income minorities. Mult Scler 2005;11: 635-640.
19. Schmotzer GL. Barriers and facilitators to participation of minorities in clinical trials. Ethn Dis 2012; 22:226-230.
20. Guendelman S, Wagner TH. Health services utilization among Latinos and white non-Latinos: results from a national survey. J Health Care Poor Underserved 2000;11:179-194.